SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MEDX ... anybody following?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2240 62 0 MEDX
Emcee:  Ed Offstein Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1790Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonaIcebrg-7/4/2007
1789Erik predicted something of the sort a week or so ago.tom pope-7/3/2007
1788Yesterday's news .. but didn't see it posted anywhere. Medarex Grants CLJM-7/3/2007
1787>>"There is nothing more exhilarating than to be shot at without effenigel bates-7/3/2007
1786A "trial" like no other. Compassionate Use Trial for Unresectable MelIcebrg-7/3/2007
1785"There is nothing more exhilarating than to be shot at without effect."tom r. phillips-7/2/2007
1784Maybe Merck/Serono, in one of their post-merger reviews, came to the conclusion Icebrg-7/2/2007
1783This seems unlikely since it was not mentioned, but could the return be for antituck-7/2/2007
1782Genmab 'Celebrating' Return Of Worldwide HuMax-CD4 Rights By Jennifer BoIcebrg-7/2/2007
1781As for "excited", I'm sure your compatriots who defused that wiredtom pope-6/29/2007
1780Excited I could believe. After all, being shot at (for example) is said to be exnigel bates-6/29/2007
1779or excited, that also works.tom pope-6/29/2007
1778That's part of the training for persons wanting to become biotech managers. Icebrg-6/29/2007
1777<"We are very enthusiastic about having HuMax-CD4 back in the hands of..kenhott-6/29/2007
1776Genmab Regains Rights to HuMax-CD4 COPENHAGEN, June 29 /PRNewswire/ -- - Plans nigel bates-6/29/2007
1775Advent grows life sciences team Oliver Smiddy 26 Jun 2007 [They forgot to mentIcebrg-6/27/2007
1774Blockade of interferon-gamma-inducible protein-10 attenuates chronic experimentaIcebrg-6/27/2007
1773He will file a Form 4 in a couple of day's time to mark his first raid at thIcebrg-6/23/2007
1772And has no directors' qualifying shares?tom pope-6/22/2007
1771Pien has filed an empty Form 3 today. I guess, that means he is now formally in Icebrg-6/22/2007
1770Duke, GBM and CELLDEX THERAPEUTICS INITIATES PHASE 2/3 TRIAL OF CDX110. therapeutom r. phillips-6/22/2007
1769Rearview mirror By Stacy Lawrence Senior Writer [source: BioCentury] In June 20Icebrg-6/22/2007
1768Metastatic Melanoma : CTLA-4 Analysis Leaves us Bullish on M.. JPMorgan (GeoffrIcebrg-6/22/2007
1767Combination of Tumor Site–Located CTL-Associated Antigen-4 Blockade and SystemicIcebrg-6/21/2007
1766{alpha}v Integrin-Targeted Immunoconjugates Regress Established Human Tumors in Icebrg-6/21/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News